Adaptive Biotechnologies Correlations
ADPT Stock | USD 8.22 0.02 0.24% |
The current 90-days correlation between Adaptive Biotechnologies and Beam Therapeutics is 0.38 (i.e., Weak diversification). The correlation of Adaptive Biotechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Adaptive Biotechnologies Correlation With Market
Very weak diversification
The correlation between Adaptive Biotechnologies Corp and DJI is 0.42 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Adaptive Biotechnologies Corp and DJI in the same portfolio, assuming nothing else is changed.
Adaptive |
Moving together with Adaptive Stock
Moving against Adaptive Stock
0.58 | VERA | Vera Therapeutics | PairCorr |
0.48 | DRMA | Dermata Therapeutics Buyout Trend | PairCorr |
0.43 | ME | 23Andme Holding | PairCorr |
0.58 | VINC | Vincerx Pharma | PairCorr |
0.53 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.46 | VRAX | Virax Biolabs Group | PairCorr |
0.42 | VKTX | Viking Therapeutics | PairCorr |
0.37 | DYAI | Dyadic International | PairCorr |
0.36 | VRDN | Viridian Therapeutics | PairCorr |
0.36 | VTYX | Ventyx Biosciences | PairCorr |
0.56 | ENVB | Enveric Biosciences | PairCorr |
0.52 | ENSC | Ensysce Biosciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Adaptive Stock performing well and Adaptive Biotechnologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Adaptive Biotechnologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
VERV | 4.44 | 0.26 | 0.05 | 0.28 | 4.81 | 11.11 | 30.05 | |||
BEAM | 3.43 | (0.17) | 0.00 | (0.15) | 0.00 | 6.41 | 23.04 | |||
CRBU | 3.35 | (0.73) | 0.00 | (0.49) | 0.00 | 5.66 | 17.85 | |||
SANA | 7.65 | 1.51 | 0.19 | 0.46 | 6.55 | 10.15 | 178.30 | |||
VECT | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
KNTE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RPRX | 1.07 | 0.37 | 0.25 | (2.45) | 1.14 | 2.11 | 19.08 | |||
IKNA | 2.06 | (0.25) | 0.00 | (0.56) | 0.00 | 4.65 | 16.13 | |||
CWBR | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
HEPA | 9.75 | (4.18) | 0.00 | (4.82) | 0.00 | 16.37 | 90.05 |
Adaptive Biotechnologies Corporate Management
Stacy JD | General VP | Profile | |
Stacy Taylor | General VP | Profile | |
Yi Zhou | Chief Officer | Profile | |
Tycho Peterson | Chief Officer | Profile | |
Kyle Piskel | Principal Officer | Profile | |
Susan Bobulsky | Chief MRD | Profile |